Report Detail
Global Armodafinil Market Growth (Status and Outlook) 2019-2024
- RnM3154455 |
- 20 March, 2019 |
- Global |
- 115 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Armodafinil (trade name Nuvigil) is the enantiopure compound of the eugeroic modafinil (Provigil). It consists of only the (R)-(−)-enantiomer of the racemic modafinil.
According to this study, over the next five years the Armodafinil market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Armodafinil business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Armodafinil market by product type, application, key companies and key regions.
This study considers the Armodafinil value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
50 mg Tablets
150 mg Tablets
250 mg Tablets
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Obstructive Sleep Apnea (OSA) and Narcolepsy
Shift Work Disorder (SWD)
Patients with Severe Hepatic Impairment
Geriatric Patients
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Teva
Mylan
Apotex
Lupin
Sandoz
Natco Pharma
Aurobindo
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Armodafinil market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Armodafinil market by identifying its various subsegments.
Focuses on the key global Armodafinil players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Armodafinil with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Armodafinil submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Armodafinil Market Report (Status and Outlook)
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Armodafinil Market Size 2014-2024
- 2.1.2 Armodafinil Market Size CAGR by Region
- 2.2 Armodafinil Segment by Type
- 2.2.1 50 mg Tablets
- 2.2.2 150 mg Tablets
- 2.2.3 200 mg Tablets
- 2.2.4 250 mg Tablets
- 2.3 Armodafinil Market Size by Type
- 2.3.1 Global Armodafinil Market Size Market Share by Type (2014-2019)
- 2.3.2 Global Armodafinil Market Size Growth Rate by Type (2014-2019)
- 2.4 Armodafinil Segment by Application
- 2.4.1 Obstructive Sleep Apnea (OSA) and Narcolepsy
- 2.4.2 Shift Work Disorder (SWD)
- 2.4.3 Patients with Severe Hepatic Impairment
- 2.4.4 Geriatric Patients
- 2.5 Armodafinil Market Size by Application
- 2.5.1 Global Armodafinil Market Size Market Share by Application (2014-2019)
- 2.5.2 Global Armodafinil Market Size Growth Rate by Application (2014-2019)
3 Global Armodafinil by Players
- 3.1 Global Armodafinil Market Size Market Share by Players
- 3.1.1 Global Armodafinil Market Size by Players (2017-2019)
- 3.1.2 Global Armodafinil Market Size Market Share by Players (2017-2019)
- 3.2 Global Armodafinil Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Armodafinil by Regions
- 4.1 Armodafinil Market Size by Regions
- 4.2 Americas Armodafinil Market Size Growth
- 4.3 APAC Armodafinil Market Size Growth
- 4.4 Europe Armodafinil Market Size Growth
- 4.5 Middle East & Africa Armodafinil Market Size Growth
5 Americas
- 5.1 Americas Armodafinil Market Size by Countries
- 5.2 Americas Armodafinil Market Size by Type
- 5.3 Americas Armodafinil Market Size by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Armodafinil Market Size by Countries
- 6.2 APAC Armodafinil Market Size by Type
- 6.3 APAC Armodafinil Market Size by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Armodafinil by Countries
- 7.2 Europe Armodafinil Market Size by Type
- 7.3 Europe Armodafinil Market Size by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Armodafinil by Countries
- 8.2 Middle East & Africa Armodafinil Market Size by Type
- 8.3 Middle East & Africa Armodafinil Market Size by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global Armodafinil Market Forecast
- 10.1 Global Armodafinil Market Size Forecast (2019-2024)
- 10.2 Global Armodafinil Forecast by Regions
- 10.2.1 Global Armodafinil Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
- 10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
- 10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
- 10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
- 10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
- 10.7 Global Armodafinil Forecast by Type
- 10.8 Global Armodafinil Forecast by Application
11 Key Players Analysis
- 11.1 Teva
- 11.1.1 Company Details
- 11.1.2 Armodafinil Product Offered
- 11.1.3 Teva Armodafinil Revenue, Gross Margin and Market Share (2017-2019)
- 11.1.4 Main Business Overview
- 11.1.5 Teva News
- 11.2 Mylan
- 11.2.1 Company Details
- 11.2.2 Armodafinil Product Offered
- 11.2.3 Mylan Armodafinil Revenue, Gross Margin and Market Share (2017-2019)
- 11.2.4 Main Business Overview
- 11.2.5 Mylan News
- 11.3 Apotex
- 11.3.1 Company Details
- 11.3.2 Armodafinil Product Offered
- 11.3.3 Apotex Armodafinil Revenue, Gross Margin and Market Share (2017-2019)
- 11.3.4 Main Business Overview
- 11.3.5 Apotex News
- 11.4 Lupin
- 11.4.1 Company Details
- 11.4.2 Armodafinil Product Offered
- 11.4.3 Lupin Armodafinil Revenue, Gross Margin and Market Share (2017-2019)
- 11.4.4 Main Business Overview
- 11.4.5 Lupin News
- 11.5 Sandoz
- 11.5.1 Company Details
- 11.5.2 Armodafinil Product Offered
- 11.5.3 Sandoz Armodafinil Revenue, Gross Margin and Market Share (2017-2019)
- 11.5.4 Main Business Overview
- 11.5.5 Sandoz News
- 11.6 Natco Pharma
- 11.6.1 Company Details
- 11.6.2 Armodafinil Product Offered
- 11.6.3 Natco Pharma Armodafinil Revenue, Gross Margin and Market Share (2017-2019)
- 11.6.4 Main Business Overview
- 11.6.5 Natco Pharma News
- 11.7 Aurobindo
- 11.7.1 Company Details
- 11.7.2 Armodafinil Product Offered
- 11.7.3 Aurobindo Armodafinil Revenue, Gross Margin and Market Share (2017-2019)
- 11.7.4 Main Business Overview
- 11.7.5 Aurobindo News
...
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Armodafinil . Industry analysis & Market Report on Armodafinil is a syndicated market report, published as Global Armodafinil Market Growth (Status and Outlook) 2019-2024. It is complete Research Study and Industry Analysis of Armodafinil market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
